• Blog Pic 2 photo BlogPic2.jpeg
    • Another differentiator is global market specific content generation. Driving sig sub growth in South Korea & Israel. $NFLX ,
  • Welcome to Life Science Deal Flow!

    Welcome to the personal blog of Adam Rubenstein. Here read about how an obsessive fascination with Innovation Intelligence can function to accelerate the commercialization of global R&D. And perhaps also some thoughts on poetry, (bio)pharma, cool science, chihuahuas and college football. Visit Covalent Data.

Only Got ‘Lil Glucose in My Pathway… For all you crazy biochem kids and your Krebs Cycle. Enjoy this little diddy. (For those reading this in email or RSS click HERE to view)

Come meet and network with Life Science Deal Flow and OnBioVC at our Office Hours on 08 July in Cambridge, MA. For details on oHours (time/place) and to sign-up for a time slot visit HERE. We look forward to connecting with you! [Trouble with the oHours sign-up link? Then paste this url in your browser […]

Our Life Science Deal Flow PDUFA Trade Strategy is not applicable to just any approaching date. There are several dates this month; Celgene’s (Nasdaq: CELG) istodax®, for relapsed and refractory peripheral T-cell lymphoma, Acura Pharmaceutical’s (Nasdaq: ACUR) acurox®, an abuse-resistant pain med, and Fibrorcell Science’s (Nasdaq: FCSC) iaviv®, for the treatment of moderate to serve […]

OnBioVC and Life Science Deal Flow are excited to announce our newest premium content site, The Email MBA, a resource to address simple to sophisticated business questions and quandaries; designed for those who are short on time and long on the desire to better understand critical concepts, from venture financings to IP management to term-sheet strategy, and much more. […]

Apologies…It appears as though the video has been taken down? In the whole wide lab… If you are reading this in email or a RSS feeder be certain to click [HERE] for the most beautiful girl in the lab; courtesy of the endlessly entertaining grad students at UCSF.

« Previous Page« Previous Entries  Next Entries »Next Page »

to top of page...